Double antibiotic attack on staph blood infections shows promise

NCT ID NCT07148960

ENROLLING_BY_INVITATION Disease control Sponsor: West Virginia University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether giving two IV antibiotics early, instead of one, can clear Staphylococcus aureus bloodstream infections faster and improve outcomes. About 300 hospitalized adults will be randomly assigned to receive either a single antibiotic or a combination of two. Once the infection clears, patients switch to oral antibiotics and are followed for 12 weeks after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: antibiotics (daptomycin, ceftaroline, rifampin, cefazolin, ertapenem, vancomycin)
What this could lead to: If it works, this could show that starting two IV antibiotics early helps clear Staph blood infections faster and reduces complications.
What could go wrong: This is a Phase 4 trial, but results may not apply to all hospitals or patients. Adding more antibiotics can raise the risk of side effects or drug resistance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BACTEREMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

staphylococcus aureus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STAPHYLOCOCCUS AUREUS BACTEREMIA

Contacts and locations

Locations

West Virginia University

Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.